- Home
- SIFY vs PHAT Comparison
SIFY vs PHAT Comparison
Compare SIFY & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIFY
- PHAT
- Stock Information
- Founded
- SIFY 1995
- PHAT 2018
- Country
- SIFY India
- PHAT United States
- Employees
- SIFY N/A
- PHAT N/A
- Industry
- SIFY Computer Software: Programming Data Processing
- PHAT Biotechnology: Pharmaceutical Preparations
- Sector
- SIFY Technology
- PHAT Health Care
- Exchange
- SIFY Nasdaq
- PHAT Nasdaq
- Market Cap
- SIFY 844.3M
- PHAT 942.6M
- IPO Year
- SIFY 1999
- PHAT 2019
- Fundamental
- Price
- SIFY $11.91
- PHAT $15.10
- Analyst Decision
- SIFY
- PHAT Strong Buy
- Analyst Count
- SIFY 0
- PHAT 5
- Target Price
- SIFY N/A
- PHAT $17.60
- AVG Volume (30 Days)
- SIFY 144.6K
- PHAT 957.4K
- Earning Date
- SIFY 10-25-2025
- PHAT 10-30-2025
- Dividend Yield
- SIFY N/A
- PHAT N/A
- EPS Growth
- SIFY N/A
- PHAT N/A
- EPS
- SIFY N/A
- PHAT N/A
- Revenue
- SIFY $466,559,277.00
- PHAT $147,190,000.00
- Revenue This Year
- SIFY N/A
- PHAT $218.38
- Revenue Next Year
- SIFY $12.69
- PHAT $87.14
- P/E Ratio
- SIFY N/A
- PHAT N/A
- Revenue Growth
- SIFY 9.09
- PHAT 460.30
- 52 Week Low
- SIFY $2.72
- PHAT $2.21
- 52 Week High
- SIFY $17.85
- PHAT $16.08
- Technical
- Relative Strength Index (RSI)
- SIFY 49.92
- PHAT 67.34
- Support Level
- SIFY $10.53
- PHAT $14.07
- Resistance Level
- SIFY $11.94
- PHAT $15.28
- Average True Range (ATR)
- SIFY 0.84
- PHAT 1.08
- MACD
- SIFY 0.02
- PHAT 0.08
- Stochastic Oscillator
- SIFY 56.18
- PHAT 73.90
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.